% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Apr 18, 2013 11:04 AM Flag

    Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

    Currently #24 of 43 (!!!!) at clinicaltrialsdotgov...
    A relatively large p2 NCI-sponsored trial, enrolling 150...presumably in addition to the RCC trial EXEL is planning later this year. I haven't but barely glanced at the other new trial announcements, but we've gained another 10% in clinical mojo this week alone!!!

9.18+0.23(+2.57%)Jul 29 4:00 PMEDT